台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

佳醫

(4104)
可現股當沖
  • 股價
    91.3
  • 漲跌
    ▲0.6
  • 漲幅
    +0.66%
  • 成交量
    125
  • 產業
    上市 生技醫療類股
  • 331人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
佳醫 (4104)籌碼相關-陽信 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

陽信 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0600.00192.0092.40-1293-0.34%
2024/04/25191.5000.0091.8012820.35%
2024/04/1800.00294.3094.60-2266-0.75%
2024/04/17294.6000.0094.6022590.77%
2024/03/0700.00289.8089.60-2167-1.20%
2024/02/1500.00386.5086.80-3136-2.20%
2023/12/20588.0000.0088.5051613.09%
2023/05/19192.3000.0091.5016090.16%
2023/05/0300.000.593.1095.70-0.5565-0.09%
2023/04/120.581.5000.0081.500.54680.11%
2023/03/1600.000.378.3078.00-0.3460-0.05%
2023/03/1000.000.578.4078.40-0.5452-0.11%
2023/02/21178.70179.6079.8003900.00%
2022/12/13166.8000.0065.7012070.48%
2022/12/0700.000.564.4064.40-0.5197-0.25%
2022/11/070.562.4000.0062.400.52250.22%
2022/10/2100.000.160.6060.50-0.1228-0.04%
2022/08/2400.00166.9066.80-1223-0.45%
2022/08/12165.4000.0065.7012130.47%
2021/05/1100.00158.4058.00-1289-0.35%
2021/01/22254.8500.0054.6022180.92%
2021/01/0500.00155.9055.90-1203-0.49%
2020/12/1500.00156.5056.10-1198-0.50%
2020/12/1400.00356.5056.60-3195-1.53%
2020/11/10157.1000.0056.9012510.40%
2020/10/15156.7000.0056.3013700.27%
2020/07/07562.00561.6061.6005710.00%
2020/06/18159.6000.0059.6014840.21%
2020/05/2200.00156.1057.00-1406-0.25%
2020/05/18255.7000.0055.4023660.55%
2020/05/15155.2000.0054.9013580.28%
2020/05/07156.0000.0056.0013310.30%
2020/04/2100.00151.8051.70-1314-0.32%
2020/03/03252.80252.6052.8002550.00%
2020/01/3100.00153.0052.90-1272-0.37%
2020/01/30253.75153.0053.0012700.37%
2020/01/1400.00153.7053.80-1246-0.41%
2020/01/0700.000.653.0053.10-0.6243-0.25%
2019/10/16153.3000.0053.2013800.26%
2019/09/2300.00253.5053.50-2412-0.49%
2019/09/1700.00153.0053.10-1410-0.24%
2019/07/18154.8000.0054.8012550.39%
2019/06/21151.5000.0051.6011840.54%
2019/05/2800.00250.8050.80-2174-1.15%
2019/05/2200.00250.3050.30-2166-1.20%
2019/05/17149.9500.0050.1011660.60%
2019/05/1600.00250.0550.10-2172-1.16%
2019/05/1500.00249.6049.50-2165-1.21%
2019/04/2400.00149.5049.50-1176-0.57%
2019/04/23249.25149.1549.1511760.57%
2019/04/1800.00249.4049.40-2185-1.08%
2019/04/17149.4000.0049.4511870.53%
2019/04/11249.40549.7749.40-3205-1.46%
2019/04/03249.4500.0049.3022010.99%
2019/03/28149.50149.5549.5501930.00%
2019/03/27449.83250.1049.8021891.05%
2019/03/2600.00349.2749.35-3182-1.65%
2019/03/2500.00148.9048.85-1179-0.56%
2019/03/21548.9000.0048.9051752.85%
2019/02/22148.4500.0048.3011610.62%
2019/02/18348.7300.0048.7531561.91%
2019/02/13148.3000.0048.2511470.68%
2019/01/3000.00348.3748.30-3145-2.06%
2019/01/2900.00348.2348.20-3142-2.11%
2019/01/28248.50148.3548.1511380.72%
2019/01/2500.00348.2048.20-3133-2.25%
2019/01/24148.25148.1548.1501310.00%
2019/01/23248.00147.9548.0011290.77%
2019/01/22147.5500.0047.5511280.78%
2019/01/21247.6000.0047.6021291.54%
2019/01/18147.5000.0047.5011330.75%
2019/01/1700.00147.7047.60-1135-0.74%
2019/01/16147.7000.0047.7011350.74%
2019/01/15347.6200.0047.5031352.21%
2019/01/14247.8000.0047.7021341.49%
2019/01/04546.80546.7046.7001290.00%
2018/11/2600.001445.1545.05-14166-8.42%
2018/11/23245.0800.0045.0521661.20%
2018/11/16145.3000.0045.3011690.59%
2018/11/13145.0000.0045.2511710.58%
2018/11/09345.0700.0045.1031761.70%
2018/11/08345.2800.0045.3031881.59%
2018/11/07445.1800.0045.1541912.09%
2018/08/0700.00150.5050.70-1459-0.22%
2018/08/06150.7000.0050.9014640.22%
2018/07/1700.00650.9051.10-6798-0.75%
2018/05/21550.5000.0050.4058310.60%
2018/05/18150.5000.0050.5018270.12%
2018/05/0900.001051.9051.50-10762-1.31%
2018/05/071052.2500.0051.80107021.42%
2018/04/2400.00149.7048.50-1491-0.20%
2018/04/23149.6000.0050.0014780.21%
2018/04/1900.00148.5548.50-1475-0.21%
2018/03/3100.00148.5048.70-1357-0.28%
2018/03/3000.00548.2548.25-5339-1.47%
2018/03/29148.4000.0048.3513270.31%
2018/03/28547.60547.6047.6002920.00%
2018/02/0100.00145.7545.85-1278-0.36%
2018/01/17545.6500.0045.6552561.95%
2018/01/15145.8000.0046.1512470.40%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音